Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity
Adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide (NAD+) are released as danger signals from cells during infection and sterile inflammation. In the extracellular compartment ATP is converted by CD39, CD73, and other ecto-enzymes into metabolites that modulate the activity of T cell...
Saved in:
Main Authors: | Stephan Menzel (Author), Nicole Schwarz (Author), Friedrich Haag (Author), Friedrich Koch-Nolte (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs
by: Carolina Pinto-Espinoza, et al.
Published: (2022) -
Use of Humanized Mouse Models to Investigate the Roles of Purinergic Signaling in Inflammation and Immunity
by: Ronald Sluyter, et al.
Published: (2020) -
Purinergic Signalling in Immune System Regulation in Health and Disease
by: Jean Sévigny, et al.
Published: (2015) -
Purinergic Signaling in Neuroinflammation
Published: (2023) -
Purinergic Receptors in Ocular Inflammation
by: Ana Guzman-Aranguez, et al.
Published: (2014)